Available online on 15.06.2023 at http://jddtonline.info
Journal of Drug Delivery and Therapeutics
Open Access to Pharmaceutical and Medical Research
Copyright © 2023 The Author(s): This is an open-access article distributed under the terms of the CC BY-NC 4.0 which permits unrestricted use, distribution, and reproduction in any medium for non-commercial use provided the original author and source are credited
Open Access Full Text Article Research Article
Assay of Diphenhydramine HCl in Syrup by High Performance Liquid Chromatography
Joko Sulistiyo
Health Polytechnic of Jakarta II, Jakarta, Indonesia
|
Article Info: _____________________________________________ Article History: Received 23 April 2023 Reviewed 14 May 2023 Accepted 27 May 2023 Published 15 June 2023 _____________________________________________ Cite this article as: Sulistiyo J, Assay of Diphenhydramine HCl in Syrup by High Performance Liquid Chromatography, Journal of Drug Delivery and Therapeutics. 2023; 13(6):141-144 DOI: http://dx.doi.org/10.22270/jddt.v13i6.5885 _____________________________________________ *Address for Correspondence: Joko Sulistiyo, Health Polytechnic of Jakarta II, Indonesia |
Abstract _____________________________________________________________________________________________________________________ Cough is a natural response from the respiratory tract by increasing the clearance of secretions and particles from mucus, irritants, foreign particles, and microbes, so that it can act as a body defense. One way that can be done to relieve cough symptoms is to use symptomatic drugs. Diphenhydramine HCl is an antihistamine that belongs to the first generation H1 receptor antagonist (H1 blocker) group which has sedative and anti-allergic properties. Diphenhydramine HCl is used to treat sneeze, runny nose, watery eyes, itches, skin rashes, and other cold symptoms or other allergies. Diphenhydramine HCl is also used to treat motion sickness and to induce sleep. The purpose of this study was to determine the contents of diphenhydramine HCl syrup sold in the market. This test uses the High Performance Liquid Chromatography (HPLC) method with acetonitrile as a mobile phase; water; triethylamine (50;50;0.5). The results obtained the average content of Diphenhydramine HCl 102.5%. So it can be concluded that the cough medicine sample meets the requirements because the contents are not less than 90% and not more than 110% based on the Indonesian Pharmacopoeia Edition VI 2020. Keywords: Cough, Diphenhydramine HCl, High Performance Liquid Chromatography (HPLC) |
INTRODUCTION
Coughing is a natural response from the respiratory tract by increasing the cleaning of secretions and particles from mucus, irritants, foreign particles, and microbes, so that they can act as the body's defense. There are two types of cough, namely productive cough (phlegm) and non-productive cough (dry). A productive cough is a cough that produces phlegm or mucus (sputum) so it is known as a cough with phlegm. Non-productive cough is a cough without phlegm, this cough is often triggered by food particles, irritants, cigarette smoke, and changes in temperature.1–4
One way that can be done to relieve cough symptoms is to use symptomatic drugs. There are many types of drugs used in cough management, depending on the type of cough that has the most effect on cough symptoms. Based on their mechanism of action, cough medicines can be grouped into 3 major groups, namely: expectorants, which have two mechanisms of action. First, it reacts directly by stimulating mucus secretion so that mucus is thinner and easier to remove. Second, by reacting indirectly by irritating the gastrointestinal tract which affects the respiratory system thereby increasing mucus secretion; mucolytic, as the name implies, mucolytic is a cough medicine with phlegm that works by destroying phlegm formations so that the phlegm becomes watery; and antitussive, are drugs that work to reduce the sensitivity of the cough center in the brain to incoming stimuli.5–7
Diphenhydramine HCl is an antihistamine which belongs to the first generation of H1 receptor antagonists (H1 blockers) which has sedative and antiallergic properties. Diphenhydramine HCl is used to treat sneezing, runny nose, watery eyes, itching, skin rashes, and other cold or allergy symptoms. Diphenhydramine HCl is also used to treat motion sickness and to induce sleep. Diphenhydramine HCl has physical properties in the form of a white crystalline powder, odorless and has a bitter taste. Diphenhydramine HCl is easily soluble in water, in ethanol, and in chloroform; slightly soluble in acetone; very difficult to dissolve in benzene and in ether.8,9 Because there are already many companies that produce the drug Diphenhydramine HCl, it is necessary to test the drug preparation with several existing parameters and according to the requirements. A quality drug is a drug that is guaranteed that the drug has the potential or power to be used for its purpose, meets purity requirements, has clear and correct identity and labeling, is packaged in appropriate packaging and is protected from damage and contamination, looks good, and is free from contamination. from defects or damage.10
Drugs that are marketed in dosage form in the form of syrup must go through several testing processes. One of them is the determination of the levels of active substance preparations. The author wants to know whether the drug Diphenhydramine HCl in the form of syrup that is circulating in the market is of good quality to be marketed to the public or not.11,12
METHODS AND MATERIALS
The method used in this test uses High Performance Liquid Chromatography (HPLC) after dilution. This test was carried out on April 25, 2022. This test was carried out at Laboratory F 2.5. Department of Pharmacy and Food Analysis, Jakarta II Health Polytechnic. The test scheme is carried out in several stages:
Standard Solution
Test Solution
Mobile Phase
Tools used in the determination of Diphenhydramine HCL levels in syrup preparations by high performance liquid chromatography (HPLC), such as: Erlenmeyer, ultrasonic, measuring cup, beaker glass, syringe, syringe, magnetic stirrer, volume pipette, 0.45 µm membrane filter, pH meters, volumetric flasks, test tubes, test tube racks, filler pipettes, stir bars, and High Performance Liquid Chromatography (HPLC). The materials used were samples, standard Diphenhydramine HCl, aquabidest, acetonitrile p, triethylamine p, glacial acetic acid, ethanol, and methanol for hplc. The sample data as follows:
Sample Data
Standard Data
In high performance liquid chromatography (HPLC), system suitability tests include: Standard Deviation, Average Standard Deviation (RSD). Then do the calculation of sample content with % Sample Content and finally do the calculation of the Dixon test which is used to select the results of the proficiency test data. If there is data that provides a value outside most of the data set.
as a requirement, based on the Indonesian Pharmacopoeia Edition VI Diphenhydramine Hydrochloride Oral Solution contains Diphenhydramine hydrochloride, πΆ17π»21ππ. π»πΆπ, not less than 90.0% and not more than 110.0% of the amount stated on the label.
RESULTS
Table 1: Sample and standard organoleptic data
|
Description |
Sample |
Standard |
|
Form |
Liquid |
Powder |
|
smell |
Fragrant |
Odorless |
|
Color |
Green |
White |
|
Flavor |
Sweet |
Bitter |
Table 2: Data on retention time and area
|
No |
Retention Time (Minutes) |
Area |
|
1 |
3,698 |
1015,42169 |
|
2 |
3,691 |
904,47369 |
|
3 |
3,684 |
976,06976 |
|
4 |
3,674 |
1072,15051 |
|
5 |
3,671 |
1052,04724 |
|
6 |
3.660 |
1044,59705 |
|
π₯Μ |
3,6796 |
1010,79332 |
|
%RSD |
0,4001 |
6,12 |
Table 3: Follow-up Factor Data
|
No |
Follow-up Factor |
|
1 |
1,5 |
|
2 |
2,25 |
|
3 |
1,75 |
|
4 |
1,75 |
|
5 |
1,25 |
|
6 |
1,5 |
|
π₯Μ |
1,66 |
Table 4: Standard Weighing Data of Diphenhydramine HCl
|
Information |
Standard Weight (g) |
|
Container Weight |
0,0793 |
|
Container Weight + Material |
0,0920 |
|
Container Weight + Residual |
0,0795 |
|
Material Weight |
0,0125 |
Table 5: Data on retention time and standard and sample area
|
No |
Information |
Retention Time |
Area |
|
1 |
Standard |
3,674 |
1072,15051 |
|
2 |
Sample K 1 |
3,664 |
1119,79700 |
|
3 |
Sample K 2 |
3,660 |
1059,44373 |
|
4 |
Sample K 3 |
3,661 |
1046,01184 |
|
5 |
Sample K 4 |
3,659 |
1042,40271 |
|
6 |
Sample K 5 |
3,656 |
1084,65833 |
Table 6: Precision Calculation Based on Retention Time
|
No |
Retention Time |
|xi - πΜ | |
|xi - πΜ |π |
|
1 |
3,698 |
0,0184 |
0,00033856 |
|
2 |
3,691 |
0,0114 |
0,00012996 |
|
3 |
3,684 |
0,0044 |
0,00001936 |
|
4 |
3,674 |
0,0056 |
0,00003136 |
|
5 |
3,671 |
0,0086 |
0,00007396 |
|
6 |
3,660 |
0,0196 |
0,00038416 |
|
∑ |
22,078 |
0,068 |
0,00097736 |
|
πΜ |
3,6796 |
0,0113 |
0,0001628293 |
Table 7: Precision Calculation Based on Area
|
No |
Area |
|xi - πΜ | |
|xi - πΜ |π |
|
1 |
1015,42169 |
4,62837 |
21,42180 |
|
2 |
904,47369 |
106,31936 |
1130,386372 |
|
3 |
976,06976 |
34,72356 |
1205,72561 |
|
4 |
1072,15051 |
61,35719 |
3764,70476 |
|
5 |
1052,04724 |
41,25392 |
1701,88591 |
|
6 |
1044,59705 |
33,80373 |
1142,69216 |
|
∑ |
6064,75994 |
282,0864 |
19140,29396 |
|
πΜ |
1010,79332 |
47,0144 |
3190,04899 |
Table 8: Dixon Test Sample Content Data
|
Information |
Data |
Level % |
|
X1 |
Sample K 1 |
99.78% |
|
X2 |
Sample K 2 |
100.13% |
|
X3 |
Sample K 3 |
101.42% |
|
X4 |
Sample K 4 |
103.83% |
|
X5 |
Sample K 5 |
107.19% |
Table 9: Precision Calculation of Sample Content
|
No |
Level % |
|xi - πΜ | |
|xi - πΜ |π |
|
1 |
107,19 |
4,72 |
22,2784 |
|
2 |
101,42 |
1,05 |
1,1025 |
|
3 |
100,13 |
2,34 |
5,.4756 |
|
4 |
99,78 |
2,69 |
7,2361 |
|
5 |
103,83 |
1,36 |
1,8496 |
|
6 |
512,35 |
12,16 |
37,9422 |
|
∑ |
102,47 |
2,432 |
7,58844 |
|
πΜ |
107,19 |
4,72 |
22,2784 |
DISCUSSION
The assay was carried out based on the procedures in the Indonesian Pharmacopoeia VI Edition 2020. In preparing the test solution, 10 mL was pipetted into a 50.0 mL volumetric flask aiming to obtain a final concentration of 0.5 mg/ml, and added aquabidest as a sample solvent. Sonication was carried out for ± 5 minutes with the aim of dissolving the sample more completely. After sonication, it was adjusted with aquabidest up to the boundary mark. Filter the test solution with a porous membrane filter of 0.45 µm or smaller, this aims to obtain a solution with smaller particles so that a better separation of components can occur in the column.
In this test, the mobile phase was used with a mixture of acetonitrile p : triethylamine p : aquabidest (50 : 0.5 : 50). The 'degas' technique is carried out to remove dissolved gases. If there is gas in the mobile phase, it can cause bubbles which can cause band widening. The liquid used as the mobile phase must be very pure to avoid the entry of impurities that can interfere with the interpretation of the chromatogram.
The System Suitability Test needs to be carried out every time a high-performance liquid chromatography assay is carried out, this aims to find out that the tool is in good condition and can be trusted so that the tool can be used to carry out a test and obtain accurate analytical data. In the system suitability test, the retention time parameter was 0.38% > 2% and the area precision parameter was 6.1% > 2%. The follow-up factor obtained was 1.7 < 2. So that the area and tailing factor precision parameters met the requirements, while the area area precision parameters did not meet the requirements stated in the procedure for determining diphenhydramine HCl levels.
In this test, resolution calculations were not carried out, because the standard tested was an internal standard because the procedure used Benzophenone while in this test the standard Diphenhydramine HCl was used, which is a compound similar to Benzophenone.
Based on the results of calculating the levels of Diphenhydramine HCl syrup, it was obtained that the average sample K level was 102.5% with an RSD of 3.0%. RSD is calculated to determine the precision of the test data performed. The test data can be said to be precise if the RSD is less than 2%. Based on the test results, the sample concentrations obtained entered the range of requirements for determining the concentration of Diphenhydramine HCl oral solution according to the Indonesian Pharmacopoeia Edition VI. While the RSD samples obtained did not meet the requirements set.
At peak the chromatogram is expected to be as symmetrical as possible and as sharp as possible to ensure that the separation is efficient. RSD results that do not meet the requirements may be due to the occurrence of broadening of the peak chromatogram (band broadening). The widening of the peak chromatogram (band broadening) is influenced by three factors, namely the eddy diffusion factor, longitudinal diffusion, and mass transfer. The eddy diffusion effect is caused by differences in the time of arrival of the solute at the detector which causes the peak chromatogram to widen or become less efficient. To prevent this, the size and shape of the stationary phase particles must be uniform. In longitudinal diffusion, solute molecules tend to diffuse in all directions. The longer the solute is in the column, the greater the tendency to diffuse and this results in a widening of the peak chromatogram. This can be corrected by increasing the velocity of the mobile phase. The mass transfer effect is due to the fact that some of the solute molecules are in the mobile phase and some are in the stationary phase. If the mobile phase flows quickly while some of the solute molecules cannot get out of the stationary phase quickly, then some of the solutes leave the column late. This results in widening of the peak chromatogram as well as making the separation inefficient. The consequent mass transfer effect is improved by decreasing the velocity of the mobile phase. As a result, there is an optimum speed to obtain the most efficient separation possible.13
CONCLUSION
Based on the test for determining the concentration of Diphenhydramine HCl syrup by High Performance Liquid Chromatography (HPLC), the average sample K level was 102.5%, so that it can be concluded that the levels of Diphenhydramine HCl in the sample Meet the Requirements (MS) as stated in the requirements of the Indonesian Pharmacopoeia Monograph VI Edition 2020.
CONFLICT OF INTEREST
The authors declare that they have no conflict interests.
REFERENCES
1. Kalra M, Khatak M, Khatak S. Cold and flu: conventional vs. botanical and nutritional therapy. Int J Drug Dev Res. 2011; 3(1):314-27.
2. Van Schoor J. An approach to recommending cough mixtures in the pharmacy. Prof Nurs Today. 2019; 23(1):8-10.
3. Putcha N, Drummond MB, Connett JE, Scanlon PD, Tashkin DP, Hansel NN, et al. Chronic productive cough is associated with death in smokers with early COPD. COPD J Chronic Obstr Pulm Dis. 2014; 11(4):451-8. https://doi.org/10.3109/15412555.2013.837870
4. Faruqi S, H Morice A. Epidemiology and pathophysiology of chronic cough. Curr Respir Med Rev. 2011; 7(1):5-9. https://doi.org/10.2174/157339811794109291
5. Bettiol S, Wang K, Thompson MJ, Roberts NW, Perera R, Heneghan CJ, et al. Symptomatic treatment of the cough in whooping cough. Cochrane database Syst Rev. 2012; (5). https://doi.org/10.1002/14651858.CD003257.pub4
6. De Blasio F, Virchow JC, Polverino M, Zanasi A, Behrakis PK, Kilinç G, et al. Cough management: a practical approach. Cough. 2011; 7:1-12. https://doi.org/10.1186/1745-9974-7-7
7. Lorensia A, Yudiarso A, Arrahmah R. Evaluasi pengetahuan dan persepsi obat batuk swamedikasi oleh perokok. J MKMI (Media Kesehat Masy Indones. 2018; 14(4):395-405. https://doi.org/10.30597/mkmi.v14i4.5065
8. Fedoskova TG. What is the best drug for allergies. Antihistamines: myths and reality. Allergy. 2019;
9. Indartantri KB, Noval N, Oktaviannoor H. Formulasi dan Evaluasi Floating System Tablet Difenhidramin HCl Menggunakan Kombinasi Matriks HPMC K4M dan Na. CMC: Formulation and Evaluation of Floating System Tablet Diphenhydramine HCl Using A Combination of Matrix HPMC K4M and Na. CMC. J Surya Med. 2021; 7(1):107-14. https://doi.org/10.33084/jsm.v7i1.2634
10. Setyani W, Putri DCA. Resep dan Peracikan Obat. Sanata Dharma University Press; 2020.
11. Swaroop AP, Varun D. A glimpse on expiry date of pharmaceutical dosage forms. PHARMANEST An Int J Adv Pharm Sci. 2011; 2(5-6):423-33.
12. Musiam S, Alfian R. Validasi metode spektrofotometri UV pada analisis penetapan kadar asam mefenamat dalam sediaan tablet generik. J Ilm Ibnu Sina. 2017; 2(1):31-43.
13. Hendayana S. Kimia Pemisahanβ―: Metode Kromatografi dan Elektroforesis Modern. Malang: Remaja Rosdakarya; 2006.